This new variant is said to be locally mutated in NY and has the same evasive immunity property as B1351 (South African variant). AstraZeneca's vaccine has proven to be ineffective against B1351.
Pfizer's efficacy is also low against B1351.
Discussion forum on Singapore stocks and current affairs.
https://www.globaltimes.cn/page/202509/1344216.shtml We've also conducted our due diligence on SCS and posted our analyses about this. h...
No comments:
Post a Comment